N/A
Completed N=15
Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD
Source: ClinicalTrials.gov NCT06488157 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcomePrimary: Feasibility, as Measured by the Percentage of Caregivers Who Enroll in the Study — 37 percentage of all eligible participants
Summary
The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility and acceptability.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility, as Measured by the Percentage of Caregivers Who Enroll in the Study |
37 | — |
| PRIMARY Feasibility, as Measured by the Percentage of Tele-visits Conducted |
95.5 | — |
| SECONDARY Change in Behavioral and Psychosocial Symptoms of Dementia (BPSD) in the Patient, as Measured by the Neuropsychiatric Inventory Questionnaire |
— | — |
| SECONDARY Mean Caregiver Depression Score, as Measured by Patient Health Questionnaire-8 |
4.8; 4.5; 3.3; 3.4; 3.6; 4.5 | — |
| SECONDARY Mean Caregiver Anxiety Score, as Measured by General Anxiety Disorder-7 |
5.9; 5.0; 4.3; 3.9; 4.7; 5.0 | — |
| SECONDARY Mean Caregiver Burden Score, as Measured by the Zarit Burden Interview - Short Version |
16.6; 12.1; 10.1; 9.7; 9.6; 10.6 | — |
| SECONDARY Mean Caregiver Perception of Patient's Pain Score, as Measured by the Doloplus 2 Scale Behavioral Assessment |
5.1; 3.9; 3.7; 3.5; 3.4; 4.4 | — |
Eligibility Criteria
Inclusion Criteria
- Age ≥ 18 years old and 100 years old
Data sourced from ClinicalTrials.gov (NCT06488157). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.